Peptides 101 for Clients

Opening (1–2 min): Welcome everyone and introduce yourself by name and your WellSourced Certified Peptide Educator credential. Give a one-sentence version of your background ("I'm a health coach / personal trainer / wellness educator"). Establish the tone: "Today is a science education session — I'll share what the research says and what questions to ask your doctor. I'm not here to prescribe or recommend — I'm here to make you informed."

• Set expectations: 60-minute session, Q&A at the end
• Mention: "Everything shared today is educational — please consult your physician for medical decisions"
• If recording: mention that upfront

Context (2 min): Open with the "why now" — peptides have exploded in mainstream wellness media, yet most of the online content is either anecdotal or commercially motivated. Your job is to fill that information gap with evidence.

• Mention the volume of recent press (GLP-1s, BPC-157 coverage in major outlets)
• "You've probably heard something about this — I want to give you the real research context, not influencer content"
• Reference that these are being prescribed, compounded, and researched worldwide — this is a real and growing field

The core concept (3 min): Peptides are short chains of amino acids — smaller than proteins, which are longer chains. The key insight: peptides are signaling molecules your body already uses. They're not foreign substances — synthetic peptides are typically bio-identical to sequences your body already produces.

• Analogy: "Think of peptides as text messages your cells send each other. We're studying the message system — not hacking it."
• Examples of natural peptides: insulin (51 AAs), glucagon, growth hormone — all peptides
• Key distinction: peptides vs. steroids vs. small molecules — very different mechanisms and risk profiles
• Address the "are these natural" question early: "Many are bio-identical — made to match what your body already produces"

Mechanism overview (3 min): Peptides work by binding to specific receptors on cell surfaces, triggering a cascade of downstream effects. This specificity is a key part of the appeal — many peptides are highly targeted.

• Key pathways to cover briefly: Growth hormone secretagogue axis (most common category), inflammatory modulation (BPC-157 type mechanisms), and metabolic signaling (GLP-1 pathway)
• Keep this simple: "Different peptides talk to different receptors — like specific keys for specific locks"
• Don't go deep — your audience is wellness consumers, not biochemists. One sentence per mechanism.
• Bridge to next section: "Now that you understand what peptides are, let's talk about safety context"

Safety framing (3 min): Be honest and nuanced here. Some peptides have decades of clinical data (TA1 approved in 35+ countries; GLP-1s have extensive Phase 3 data). Others have more limited human studies. The #1 safety variable is source quality and purity, not the molecule itself in most cases.

• Explain "research chemical" classification: means not FDA-approved for clinical use, not that they're dangerous
• Contrast: semaglutide is a peptide, FDA-approved, widely prescribed — same molecule category
• The purity conversation: explain CoA testing, third-party lab verification, what to look for
• Always close this slide with: "Any clinical use decisions should involve a physician who can evaluate your individual health picture"

Research literacy (4 min): This is one of the most useful slides in the deck. Teach people to be their own BS detectors. Key framework points:

• Mouse study ≠ human outcome. But mouse data is still hypothesis-generating — not worthless, just preliminary
• "n = 12 doesn't mean it doesn't work; it means we don't know yet"
• Dose relevance: many animal studies use 100x higher doses than would be used in humans
• Industry-funded studies: not automatically invalid, but worth noting
• PubMed search tip: show the audience how to verify a citation in 30 seconds
• Transition: "Now that you know how to read the evidence, let's look at what the evidence actually says on the most commonly discussed peptides"

BPC-157 overview (4 min): Body Protection Compound-157 is a synthetic pentadecapeptide fragment (15 amino acids) derived from a protein found in gastric juice. It has one of the largest body of animal research of any research peptide.

• Strong rodent evidence for: tendon healing, muscle repair, GI inflammation reduction, nerve regeneration
• Mechanism: promotes angiogenesis (new blood vessel formation), upregulates growth factor receptors (VEGFR2, EGF receptor)
• Human data: limited formal trials, but widely used in biohacking community; compounded by some functional medicine physicians
• Common questions: "Is it safe?" — Well-tolerated in animal models; no serious adverse events in available human use data, but long-term human safety data is limited
• Route: typically subcutaneous injection or oral (GI-focused applications)

TB-500 / Thymosin Beta-4 (3 min): Thymosin Beta-4 is a naturally occurring peptide found in high concentrations in blood platelets and wound fluid. TB-500 is the synthetic version of the active fragment (Tβ4 17-23).

• Naturally involved in actin regulation, wound healing, and cellular migration
• Research focus: cardiac repair post-MI, stroke recovery, corneal healing
• Biohacking community: primarily used for musculoskeletal recovery, often combined with BPC-157
• Safety profile: no serious adverse events in published research; well-tolerated
• Key note: TB-500 is a fragment — slightly different from full Thymosin Beta-4 but likely similar activity on active region

GHK-Cu (3 min): One of the better-studied peptides with a clear cosmetic/topical application track. GHK-Cu is a naturally occurring copper peptide complex found in human plasma, saliva, and urine.

• Mechanism: stimulates collagen, elastin, and glycosaminoglycan synthesis; promotes wound healing; has antioxidant activity
• Well-documented in cosmetic research — multiple clinical trials on skin rejuvenation, wound healing
• Topical applications well-established and commercially available
• Systemic uses: being explored for lung injury, cognitive decline (preclinical), hair loss
• Good bridge for audience members interested in skin health — this is an accessible entry point into peptide science

GLP-1s (3 min): This is the slide that contextualizes peptides for people who think "peptides = underground/fringe." GLP-1 receptor agonists are peptides — FDA-approved, widely prescribed, backed by extensive Phase 3 data.

• Use this slide to build credibility: "You know Ozempic? That's a peptide. Wegovy? Peptide. Mounjaro? Peptide. This is the same molecule class."
• GLP-1 mechanism: incretin hormone mimetics — slow gastric emptying, promote satiety, stimulate insulin secretion in glucose-dependent manner, cardioprotective effects
• This doesn't mean all peptides are safe or FDA-approved — but it shows that the class has clear clinical merit
• Useful for skeptical audience members: "If GLP-1s get to be mainstream medicine, the class itself isn't fringe"

TA1 (3 min): Thymosin Alpha-1 is one of the most clinically validated immune peptides. It's approved as Zadaxin in 35+ countries for hepatitis B, hepatitis C, and as a cancer immunoadjuvant.

• Key concept: TA1 doesn't stimulate the immune system — it calibrates it. This is the correct framing: immunomodulator, not immunostimulant
• Mechanism: promotes T-cell maturation in thymus; enhances T-helper cell function; increases NK cell activity
• Biohacking appeal: general immune resilience, COVID-19 recovery protocols, longevity/immunosenescence (immune aging)
• Well-tolerated: 30+ year safety track record across clinical trials
• Good candidate for the "safe starting point" conversation with clients who want to explore peptides carefully

Goal-to-peptide mapping (4 min): This is the practical "where do I start" slide. Help the audience understand that peptide selection starts with a clear goal — not with "what's popular."

• Walk through each category briefly. Emphasize: "This is research context, not a recommendation"
• Recovery/repair: BPC-157 most studied; TB-500 often stacked; GHK-Cu for skin/topical
• Metabolic: GLP-1s have the most clinical data; AOD-9604 is a GH fragment studied for fat metabolism
• Cognitive: Semax and Selank are Russian-developed nootropic peptides with clinical data; Dihexa has preclinical data for neurogenesis
• Immune: TA1 strongest evidence base; low-dose Naltrexone (LDN) adjacent — mention the immunomodulator category
• Always: "The right peptide for your goals is a conversation to have with a qualified medical provider who can review your labs and health history"

Sourcing education (4 min): This is one of the most valuable slides for audience safety. The #1 risk with research peptides isn't the molecule — it's source quality.

• Certificate of Analysis (CoA): a lab document confirming identity and purity. Every legitimate vendor provides one per batch.
• Third-party testing: CoA must come from an independent lab — not in-house testing
• Minimum standards: purity ≥98% by HPLC; identity confirmation by mass spectrometry; batch number matches product label
• Red flags: no CoA available; single generic CoA for all products; CoA from unnamed lab; vendor deflects on testing questions
• Mention research community vetting: forums, community reputation over years, crowdsourced testing projects

Doctor conversation (4 min): This slide handles a real audience pain point — "my doctor doesn't know about peptides / won't engage."

• Normalize: most PCPs weren't trained in peptide pharmacology — it wasn't in medical school curricula 10 years ago
• Suggest: functional medicine physicians, longevity-focused MDs, and some anti-aging clinics are more familiar
• How to frame it: "I've been researching [specific peptide]. I found these studies (have PubMed citations ready). Can you help me evaluate whether this is appropriate given my health history?"
• Labs to request: baseline CBC, CMP, hormone panel (IGF-1 if GH secretagogues), thyroid panel, inflammatory markers (CRP, homocysteine)
• Key message: "You deserve a provider who will engage with your research — it may mean finding a new one"

Contraindications (3 min): Be direct and clear here. This builds trust and demonstrates that you're here to educate responsibly.

• Active cancer: Many peptides promote tissue growth and angiogenesis — could theoretically support tumor growth. Always physician review for anyone with active or recent cancer history.
• Pregnancy/breastfeeding: No safety data in pregnancy. Full stop — do not use research peptides.
• Autoimmune: Nuanced. Some peptides (BPC-157, TA1) may actually benefit certain autoimmune conditions — but immune-modulating peptides require physician oversight.
• Hormone-sensitive conditions: GH secretagogues increase IGF-1 — relevant for anyone with hormone-sensitive conditions (certain cancers, acromegaly risk)
• Deliver this with confidence: "Knowing who shouldn't use something is just as important as knowing who might benefit"

Decision framework (3 min): This slide synthesizes the entire section into a practical approach for audience members considering peptide research.

• Step 1: Define your goal. Be specific — "I want to accelerate recovery from my shoulder injury" is better than "I want to try peptides"
• Step 2: Read the primary research on peptides relevant to that goal. PubMed. Not just forums.
• Step 3: Find a provider who will engage. Bring the research to them.
• Step 4: If proceeding, start at the lower end of studied doses. Track everything: energy, sleep, any changes — in writing.
• Step 5: Get relevant labs before starting and repeat after a protocol cycle. Data over anecdote.

Educator positioning (3 min): This is about teaching the audience — and reinforcing your own framing as an educator. Say "I don't know" confidently. It's a credibility signal, not a weakness.

• Prescriber language (avoid): "You should take BPC-157 for that." "This dose is right for you." "This will fix your issue."
• Educator language (use): "The research on BPC-157 for soft tissue injury shows..." "Most protocols in the literature use..." "That's a great question for a functional medicine physician who can review your case."
• Teach this to your clients: "My role is to help you understand the research well enough to have a better conversation with your doctor."

Scripted Q&A (5 min): Walk through these 4 questions live with the audience. Model the answers.

"Are these safe?" → "Safety depends on the specific peptide, the source quality, and the individual's health context. Many well-studied peptides have strong safety records — Thymosin Alpha-1 has 30 years of clinical data. Others have limited human safety data. The universal variable is source quality — only use research peptides with verified third-party CoAs."

"Where do I get them?" → "Research peptides are available from research chemical vendors — not pharmacies (unless prescribed). The sourcing quality conversation we had is critical here. I can point you to evaluation frameworks, but I don't make specific vendor recommendations."

"What dose should I use?" → "Dosing is a clinical decision that belongs with a physician who knows your health history. I can share what dosing ranges appear in the literature — that's research context, not a prescription."

"Are these steroids?" → "No — completely different molecule class, mechanism, and risk profile. Peptides are amino acid chains. Steroids are cholesterol-derived hormones. GLP-1s are peptides and FDA-approved. The confusion comes from both being used in performance contexts, but they're not the same."

Resources & next steps (3 min): Give people concrete tools to continue their education after the workshop.

• PubMed: pubmed.ncbi.nlm.nih.gov — free access to primary research. Show them how to search "BPC-157 tissue repair" and find actual papers
• WellSourced library: wellsourced.polsia.app/peptides — curated peptide profiles based on research evidence
• Finding a provider: IFM (Institute for Functional Medicine) provider directory at ifm.org; American Academy of Anti-Aging Medicine (A4M)
• Working with you: This is your plug — mention your consultation services, pricing, what a session looks like. Keep it brief (30 seconds max) and offer a link/card.

Closing (2 min): Land the session with confidence and a clear call to action.

• Restate the 3 core takeaways: (1) Peptides are real science with a strong evidence base in key areas. (2) Source quality matters more than any other variable you can control. (3) This is not DIY — a physician who engages with your research is a non-negotiable partner.
• Thank the audience. Offer a specific next step: "If you'd like a 1:1 session to go deeper on your specific goals and research interests, my calendar link is on the handout."
• Stay in the room for informal Q&A — often the best conversations happen after the formal session ends
• Collect email signups if doing a live event — offer a "top 5 peptide research papers" resource as incentive
• Legal close (say this): "Everything shared today is educational only. Please consult a licensed healthcare provider for any medical decisions."